Höllriegel R, Linke A, Hochadel M, Schuler G, Kerber S, Hambrecht R, Grube E, Hauptmann K E, Zahn R, Zeymer U, Senges J
Department of Internal Medicine/Cardiology, University of Leipzig - Heart Center, Struempellstrasse 39, Leipzig, Germany.
Herz. 2013 Jun;38(4):387-90. doi: 10.1007/s00059-012-3712-z. Epub 2013 Jan 18.
Although aortic valve disease (AVD) is frequently associated with coronary artery disease (CAD), little is known about the impact of significant coronary artery disease on mortality after diagnostic cardiac catheterization in patients with AVD.
We analyzed data of the coronary angiography registry of the "Arbeitsgemeinschaft Leitende Kardiologische Krankenhausärzte" (ALKK) in Germany. The primary endpoint was in-hospital mortality.
A total of 1427 consecutive patients with AVD (438 patients with CAD versus 989 patients without CAD) underwent diagnostic catheterization in 2006 in 42 hospitals. All cause in-hospital mortality was more than threefold higher in patients with CAD (16/438; 3.7%) as compared to patients without CAD (12/989; 1.2%; p < 0.01; OR 3.09, 95% CI 1.45-6.58). Even after adjustment for age, sex, presence of diabetes mellitus and renal insufficiency, in-hospital all cause mortality remained statistically significant different between the two groups (OR 2.4; 95% CI 1.09-5.28; p < 0.01). Several factors, such as transient ischemic attack/stroke, volume of contrast agent, and left heart catheter-associated complications could not be identified as possible causes for the increase in mortality.
This analysis in patients with the leading diagnosis of AVD shows a significantly higher in-hospital mortality after diagnostic cardiac catheterization in case of an accompanying CAD. However, further studies are necessary to identify the driving force for the increase in mortality.
虽然主动脉瓣疾病(AVD)常与冠状动脉疾病(CAD)相关,但对于严重冠状动脉疾病对AVD患者诊断性心导管检查后死亡率的影响知之甚少。
我们分析了德国“Arbeitsgemeinschaft Leitende Kardiologische Krankenhausärzte”(ALKK)冠状动脉造影登记处的数据。主要终点是住院死亡率。
2006年,42家医院共有1427例连续的AVD患者(438例CAD患者与989例无CAD患者)接受了诊断性导管检查。CAD患者的全因住院死亡率(16/438;3.7%)比无CAD患者(12/989;1.2%)高出三倍多(p<0.01;OR 3.09,95%CI 1.45 - 6.58)。即使在调整年龄、性别、糖尿病和肾功能不全的存在情况后,两组之间住院全因死亡率仍有统计学显著差异(OR 2.4;95%CI 1.09 - 5.28;p<0.01)。一些因素,如短暂性脑缺血发作/中风、造影剂用量和左心导管相关并发症,未被确定为死亡率增加的可能原因。
这项对以AVD为主诊断的患者的分析表明,伴有CAD时,诊断性心导管检查后的住院死亡率显著更高。然而,需要进一步研究以确定死亡率增加的驱动因素。